118 related articles for article (PubMed ID: 10218883)
21. The cathepsin D (224C/T) polymorphism confers an increased risk to develop Alzheimer's disease in men.
Albayrak O; Tirniceriu A; Riemenschneider M; Kurz A; Scherag A; Egensperger R
J Gerontol A Biol Sci Med Sci; 2010 Mar; 65(3):219-24. PubMed ID: 20083556
[TBL] [Abstract][Full Text] [Related]
22. Modulation of disease risk according to a cathepsin D / apolipoprotein E genotype in Parkinson's disease.
Schulte T; Böhringer S; Schöls L; Müller T; Fischer C; Riess O; Przuntek H; Berger K; Epplen JT; Krüger R
J Neural Transm (Vienna); 2003 Jul; 110(7):749-55. PubMed ID: 12811635
[TBL] [Abstract][Full Text] [Related]
23. Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease.
McIlroy SP; Dynan KB; McGleenon BM; Lawson JT; Passmore AP
Neurosci Lett; 1999 Oct; 273(2):140-1. PubMed ID: 10505636
[TBL] [Abstract][Full Text] [Related]
24. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study.
McCusker SM; Curran MD; Dynan KB; McCullagh CD; Urquhart DD; Middleton D; Patterson CC; McIlroy SP; Passmore AP
Lancet; 2001 Feb; 357(9254):436-9. PubMed ID: 11273064
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphism in exon 2 of cathepsin D is not associated with vascular dementia.
Jeong BH; Lee KH; Lee YJ; Yun J; Park YJ; Kim YH; Cho YS; Choi EK; Carp RI; Kim YS
Acta Neurol Scand; 2011 Jun; 123(6):419-23. PubMed ID: 20597865
[TBL] [Abstract][Full Text] [Related]
26. Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population.
Schwab SG; Bagli M; Papassotiropoulos A; Jessen F; Maier W; Rao ML; Heun R
Dement Geriatr Cogn Disord; 1999; 10(6):469-72. PubMed ID: 10559561
[TBL] [Abstract][Full Text] [Related]
27. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
Bian JT; Zhang JW; Zhang ZX; Zhao HL
Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphism in the cathepsin G gene and the risk of Alzheimer's disease.
Bhojak TJ; DeKosky ST; Ganguli M; Kamboh MI
Neurosci Lett; 2001 Aug; 309(2):138-40. PubMed ID: 11502364
[TBL] [Abstract][Full Text] [Related]
29. Lack of association of cathepsin D genetic polymorphism with Alzheimer's disease in Koreans.
Jhoo JH; Park WY; Kim KW; Lee KH; Lee DY; Youn JC; Choo IH; Seo JS; Woo JI
Arch Gerontol Geriatr; 2005; 41(2):121-7. PubMed ID: 16085063
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein gene E4 allele promoter polymorphisms as risk factors for Alzheimer's disease.
Parker GR; Cathcart HM; Huang R; Lanham IS; Corder EH; Poduslo SE
Psychiatr Genet; 2005 Dec; 15(4):271-5. PubMed ID: 16314757
[TBL] [Abstract][Full Text] [Related]
31. Positive Association of the Cathepsin D Ala224Val Gene Polymorphism With the Risk of Alzheimer's Disease.
Paz-Y-Miño CA; García-Cárdenas JM; López-Cortés A; Salazar C; Serrano M; Leone PE
Am J Med Sci; 2015 Oct; 350(4):296-301. PubMed ID: 26351775
[TBL] [Abstract][Full Text] [Related]
32. Association of an interleukin 1 alpha polymorphism with Alzheimer's disease.
Du Y; Dodel RC; Eastwood BJ; Bales KR; Gao F; Lohmüller F; Müller U; Kurz A; Zimmer R; Evans RM; Hake A; Gasser T; Oertel WH; Griffin WS; Paul SM; Farlow MR
Neurology; 2000 Aug; 55(4):480-3. PubMed ID: 10953177
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease.
Styczynska M; Religa D; Pfeffer A; Luczywek E; Wasiak B; Styczynski G; Peplonska B; Gabryelewicz T; Golebiowski M; Kobrys M; Barcikowska M
Neurosci Lett; 2003 Jun; 344(2):99-102. PubMed ID: 12782337
[TBL] [Abstract][Full Text] [Related]
34. Genetic association of a cathepsin D polymorphism and sporadic Creutzfeldt-Jakob disease.
Jeong BH; Lee KH; Lee YJ; Yun J; Park YJ; Bae Y; Kim YH; Cho YS; Choi EK; Carp RI; Kim YS
Dement Geriatr Cogn Disord; 2009; 28(4):302-6. PubMed ID: 19828951
[TBL] [Abstract][Full Text] [Related]
35. A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease.
Kamboh MI; Aston CE; Perez-Tur J; Kokmen E; Ferrell RE; Hardy J; DeKosky ST
Neurosci Lett; 1999 Mar; 263(2-3):129-32. PubMed ID: 10213152
[TBL] [Abstract][Full Text] [Related]
36. The --491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease.
Alvarez-Arcaya A; Combarros O; Llorca J; Sánchez-Guerra M; Berciano J; Fernández-Luna JL
Neurosci Lett; 2001 May; 304(3):204-8. PubMed ID: 11343837
[TBL] [Abstract][Full Text] [Related]
37. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
38. The insertion polymorphism in angiotensin-converting enzyme gene associated with the APOE epsilon 4 allele increases the risk of late-onset Alzheimer disease.
Wang B; Jin F; Yang Z; Lu Z; Kan R; Li S; Zheng C; Wang L
J Mol Neurosci; 2006; 30(3):267-71. PubMed ID: 17401152
[TBL] [Abstract][Full Text] [Related]
39. The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease.
Lendon CL; Thaker U; Harris JM; McDonagh AM; Lambert JC; Chartier-Harlin MC; Iwatsubo T; Pickering-Brown SM; Mann DM
Neurosci Lett; 2002 Aug; 328(3):314-8. PubMed ID: 12147333
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.
Li G; Silverman JM; Altstiel LD; Haroutunian V; Perl DP; Purohit D; Birstein S; Lantz M; Mohs RC; Davis KL
Genet Epidemiol; 1996; 13(3):285-98. PubMed ID: 8797010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
